CompletedNot Applicable

LV Thrombus Screening in Anterior STEMI: Worth it?

Portugal68 participantsStarted 2021-02-01

Plain-language summary

Left ventricular (LV) thrombus is more common in patients with anterior ST-elevation myocardial infarction (STEMI) compared to other types of acute myocardial infarction (AMI) and is linked to worse outcomes. Diagnosing LV thrombus remains challenging. Contrast echocardiography (TTE) has potential to improve diagnostic accuracy, affecting treatment strategies involving antithrombotic/anticoagulation therapy. This study aimed to evaluate the effectiveness of contrast TTE as a routine screening method for detecting LV thrombus in the acute phase of anterior STEMI.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 years or older * Admitted due to anterior ST-elevation myocardial infarction Exclusion Criteria: * Under 18 years old * Did not undergo echocardiographic or coronary angiographic evaluation * Cardiogenic shock * Previously known thrombus * Previously known allergic contrast reaction

What they're measuring

left ventricular thrombus

Timeframe: 7 days (time of echoTT)

Trial details

NCT IDNCT06480929

SponsorCentro Hospitalar Tondela-Viseu

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-28

View on ClinicalTrials.gov More Thrombus of Left Ventricle trials